Noradrenergic response to intravenous yohimbine in patients with depression and comorbidity of depression and panic
Data up to Jan 2025
Total Citations Per Year
Abstract
References (14)
Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase.
1986 • 484 citations
Panic Disorder and Major Depression
1983 • 367 citations
Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks
1987 • 303 citations
Anxiety syndromes and their relationship to depressive illness.
1983 • 173 citations
Noradrenergic neuronal dysregulation in panic disorder: the effects of intravenous yohimbine and clonidine in panic disorder patients
1992 • 148 citations
Noradrenergic Function and the Mechanism of Action of Antianxiety Treatment
1985 • 142 citations
Panic disorder and major depression. A tale of two syndromes.
1988 • 112 citations
Yohimbine's anxiogenic action: Evidence for noradrenergic and dopaminergic sites
1989 • 93 citations
Simultaneous panic and depressive disorder: response to antidepressant treatments.
1986 • 89 citations
α2-Adrenergic Receptor Function in Depression
1986 • 87 citations
Yohimbine increases sympathetic nerve activity and norepinephrine spillover in normal volunteers
1991 • 69 citations
Sympathetic reactivity during a yohimbine challenge test in essential hypertension.
1991 • 43 citations
The effect of yohimbine, Wy 26392 and idazoxan on sympathetic nerve activity
1985 • 34 citations
Free 3-methoxy-4-hydroxyphenylglycol determined in plasma by liquid chromatography with coulometric detection.
1989 • 16 citations